|0.31||0.00 / 0.00%|
Data as of 3:59pm ET
|0.30||-0.01 / -3.23%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +383.87% increase from the last price of 0.31.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.